Obstetrical care in gestational diabetes and management of preterm labour

Diabetes and Metabolism

Volumn 36, Issue 6, 2010, Pages 672-681

  Thiebaugeorges, O ^a   Guyard Boileau, B ^b  

^a Maternite Regionale Universitaire   (France)

^b Paul Sabatier University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; FETUS MONITORING; HUMAN; METHODOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRENATAL CARE; REVIEW;

DIABETES, GESTATIONAL; FEMALE; FETAL MONITORING; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PRENATAL CARE;

MLCS; MLOWN;

EID: 79954488952     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.11.017     Document Type: Article

References (65)

1. Mulholland, C., Njoroge, T., Mersereau, P., Williams, J., Comparison of guidelines available in the United States for diagnosis and management of diabetes before, during, and after pregnancy. J Womens Health (Larchmt) 16 (2007), 790–801.
2. Vidaeff, A., Yeomans, E.R., Ramin, S.M., Gestational diabetes: a field of controversy. Obstet Gynecol Surv 58 (2003), 759–769.
3. Practice ACOG Bulletin. Clinical management Guidelines for obstetrician - gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 98 (2001), 525–538.
4. Guideline development Group. Management of diabetes from preconception to the postnatal period: summary of NICE Guidance. BMJ 336 (2008), 714–717.
5. Conway, D.L., Obstetric management in gestational diabetes. Diabetes Care 30:Suppl. 2 (2007), S175–S179.
6. Turok, D.K., Ratcliffe, S.D., Baxley, E.G., Management of gestational diabetes mellitus. Am Fam Physician 68 (2003), 1767–1772.
7. Serlin, D.C., Lash, R.W., Diagnosis and management of gestational diabetes mellitus. Am Fam Physician 80 (2009), 57–62.
8. Metzger, B.E., Buchanan, T.A., Coustan, D.R., de Leiva, A., Dunger, D.B., Hadden, D.R., et al. Summary and recommendations of the Fifth International Workshop-Conference on gestational Diabetes Mellitus. Diabetes Care 30:Suppl. 2 (2007), S251–S260.
9. Sherman, D.J., Arieli, S., Tovbin, J., Siegel, G., Caspi, E., Bukovsky, I., A comparison of clinical and ultrasonic estimation of fetal weight. Obstet Gynecol 9 (1998), 212–217.
10. Mehdizadeh, A., Alaghehbandan, R., Horsan, H., Comparison of clinical versus ultrasound estimation of fetal weight. Am J Perinatol 17 (2000), 233–236.
11. Chauhan, S.P., West, D.J., Scardo, J.A., Boyd, J.M., Joiner, J., Hendrix, N.W., Antepartum detection of macrosomic fetus: clinical versus sonographic, including soft-tissue measurements. Obstet Gynecol 95 (2000), 639–642.
12. Engstrom, J.L., Work, B.A. Jr., Prenatal prediction of small- and large for- gestational age neonates. J Obstet Gynecol Neonatal Nurs 21 (1992), 486–495.
13. Westin, B., Gravidogram and fetal growth. Comparison with biochemical supervision. Acta Obstet Gynecol Scand 56 (1977), 273–282.
14. Wikstrom, I., Bergstrom, R., Bakketeig, L., Jacobsen, G., Lindmark, G., Prediction of high birthweight from maternal characteristics, symphysis fundal height and ultrasound biometry. Gynecol Obstet Invest 35 (1993), 27–33.
15. Chauhan, S.P., Hendrix, N.W., Magann, E.F., Morrison, J.C., Kenney, S.P., Devoe, L.D., Limitations of clinical and sonographic estimates of birth weight: experience with 1034 parturients. Obstet Gynecol 91 (1998), 72–77.
16. HAS. Suivi et orientation des femmes enceintes en fonction des situations a risque identifiees, 2007.
17. Allen, V.M., Armson, B.A., Wilson, R.D., Allen, V.M., Blight, C., Gagnon, A., Teratogenicity associated with pre-existing and gestational diabetes. J Obstet Gynaecol Can 29 (2007), 927–944.
18. Rapport du Comite National Technique de l'Echographie de Depistage Prenatal. 2005.
19. Sacks, D.A., Etiology, detection, and management of fetal macrosomia in pregnancies complicated by diabetes mellitus. Clin Obstet Gynecol 50 (2007), 980–989.
20. Kehl, R.J., Krew, M.A., Thomas, A., Catalano, P.M., Fetal growth and body composition in infants of women with diabetes mellitus during pregnancy. J Matern Fetal Med 5 (1996), 273–280.
21. Bochner, C.J., Medearis, A.L., Williams, J., 3rd, Castro, L., Hobel, C.J., Wade, M.E., Early third-trimester ultrasound screening in gestational diabetes to determine the risk of macrosomia and labor dystocia at term. Am J Obstet Gynecol 157 (1987), 703–708.
22. Dudley, N.J., A systematic review of the ultrasound estimation of fetal weight. Ultrasound Obstet Gynecol 25 (2005), 80–89.
23. Hadlock, F.P., Harrist, R.B., Fearneyhough, T.C., Deter, R.L., Park, S.K., Rossavik, I.K., Use of femur length/abdominal circumference ratio in detecting the macrosomic fetus. Radiology 154 (1985), 503–505.
24. Benacerraf, B.R., Gelman, R., Frigoletto, F.D. Jr., Sonographically estimated fetal weights: accuracy and limitation. Am J Obstet Gynecol 159 (1988), 1118–1121.
25. Colman, A., Maharaj, D., Hutton, J., Tuohy, J., Reliability of ultrasound estimation of fetal weight in term singleton pregnancies. N Z Med J, 119, 2006, U2146.
26. Field, N.T., Piper, J.M., Langer, O., The effect of maternal obesity on the accuracy of fetal weight estimation. Obstet Gynecol 86 (1995), 102–107.
27. Combs, C.A., Rosenn, B., Miodovnik, M., Siddiqi, T.A., Sonographic EFW and macrosomia: is there an optimum formula to predict diabetic fetal macrosomia ?. J Matern Fetal Med 9 (2000), 55–61.
28. Hadlock, F.P., Harrist, R.B., Sharman, R.S., Deter, R.L., Park, S.K., Estimation of fetal weight with the use of head, body, and femur measurements – a prospective study. Am J Obstet Gynecol 151 (1985), 333–337.
29. Kernaghan, D., Ola, B., Fraser, R.B., Farrell, T., Owen, P., Fetal size and growth velocity in the prediction of the large for gestational age (LGA) infant in a glucose impaired population. Eur J Obstet Gynecol Reprod Biol 132 (2007), 189–192.
30. Coomarasamy, A., Connock, M., Thornton, J., Khan, K.S., Accuracy of ultrasound biometry in the prediction of macrosomia: a systematic quantitative review. BJOG 112 (2005), 1461–1466.
31. Buchanan, T.A., Kjos, S.L., Montoro, M.N., Wu, P.Y., Madrilejo, N.G., Gonzalez, M., et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 17 (1994), 275–283.
32. Kjos, S.L., Schaefer-Graf, U., Sardesi, S., Peters, R.K., Buley, A., Xiang, A.H., et al. A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care 24 (2001), 1904–1910.
33. Schaefer-Graf, U.M., Kjos, S.L., Fauzan, O.H., Buhling, K.J., Siebert, G., et al. A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care 27 (2004), 297–302.
34. Bonomo, M., Cetin, I., Pisoni, M.P., Faden, D., Mion, E., Taricco, E., et al. Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: a controlled randomized clinical trial. Diabetes Metab 30 (2004), 237–244.
35. Rossi, G., Somigliana, E., Moschetta, M., Bottani, B., Barbieri, M., Vignali, M., Adequate timing of fetal ultrasound to guide metabolic therapy in mild gestational diabetes mellitus. Results from a randomized study. Acta Obstet Gynecol Scand 79 (2000), 649–654.
36. Kjos, S.L., Schaefer-Graf, U.M., Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select strict versus relaxed maternal glycemic targets. Diabetes Care 30:Suppl. 2 (2007), S200–S205.
37. Cooper, M.J., Enderlein, M.A., Tarnoff, H., Roge, C.L., Asymmetric septal hypertrophy in infants of diabetic mothers. Fetal echocardiography and the impact of maternal diabetic control. Am J Dis Child 146 (1992), 226–229.
38. Rizzo, G., Arduini, D., Romanini, C., Doppler echocardiographic assessment of fetal cardiac function. Ultrasound Obstet Gynecol 2 (1992), 434–445.
39. Gutgesell, H.P., Mullins, C.E., Gillette, P.C., Speer, M., Rudolph, A.J., McNamara, D.G., Transient hypertrophic subaortic stenosis in infants of diabetic mothers. J Pediatr 89 (1976), 120–125.
40. Dudley, D.J., Diabetic-associated stillbirth: incidence, pathophysiology, and prevention. Obstet Gynecol Clin North Am 34 (2007), 293–307.
41. Leticee NS, Ville Y. Cardiomyopathie hypertrophique. Enquete de pratiques sur la mesure du SIV chez les foetus de meres diabetiques. In Congres de medecine foetale. Cannes: 2007.
42. Williams, K.P., Arquharson, D.F., Bebbington, M., Dansereau, J., Galerneau, F., Wilson, R.D., et al. Screening for fetal well-being in a high-risk pregnant population comparing the non stress test with umbilical artery Doppler velocimetry: a randomized controlled clinical trial. Am J Obstet Gynecol 188 (2003), 1366–1371.
43. Neilson JP, Alfi revic Z. Doppler ultrasound for fetal assessment in high-risk pregnancies. Cochrane Database Syst Rev 2000:CD000073.
44. Westergaard, H.B., et al. A critical appraisal of the use of umbilical artery Doppler ultrasound in high-risk pregnancies: use of meta-analyses in evidence-based obstetrics. Ultrasound Obstet Gynecol 17 (2001), 466–476.
45. Salvesen, K., Routine ultrasound scanning in pregnancy. BMJ, 307, 1993, 1064.
46. Wong, S.F., Chan, F.Y., Cincotta, R.B., McIntyre, D.H., Stone, M., Use of umbilical artery Doppler velocimetry in the monitoring of pregnancy in women with pre-existing diabetes. Aust N Z J Obstet Gynaecol 43 (2003), 302–306.
47. Leung, W.C., Lam, H., Lee, C.P., Lao, T.T., Doppler study of the umbilical and fetal middle cerebral arteries in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol 24 (2004), 534–537.
48. Zimmermann, P., Kujansuu, E., Tuimala, R., Doppler velocimetry of the umbilical artery in pregnancies complicated by insulin-dependent diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 47 (1992), 85–93.
49. Johnstone, F.D., Steel, J.M., Haddad, N.G., Hoskins, P.R., Greer, I.A., Chambers, S., Doppler umbilical artery flow velocity waveforms in diabetic pregnancy. Br J Obstet Gynaecol 99 (1992), 135–140.
50. Ben-Ami, M., Battino, S., Geslevich, Y., Shalev, E., A random single Doppler study of the umbilical artery in the evaluation of pregnancies complicated by diabetes. Am J Perinatol 12 (1995), 437–438.
51. Kofinas, A.D., Penry, M., Swain, M., Uteroplacental Doppler flow velocity waveform analysis correlates poorly with glycemic control in diabetic pregnant women. Am J Perinatol 8 (1991), 273–277.
52. Reece, E.A., Agay, Z., Assimakopoulos, E., Moroder, W., Gabrielli, S., DeGennaro, N., et al. Diabetes mellitus in pregnancy and the assessment of umbilical artery waveforms using pulsed Doppler ultrasonography. J Ultrasound Med 13 (1994), 73–80.
53. Bracero, L.A., Figueroa, R., Byrne, D.W., Han, H.J., Comparison of umbilical Doppler velocimetry, non stress testing, and biophysical profile in pregnancies complicated by diabetes. J Ultrasound Med 15 (1996), 301–308.
54. Kjos, S.L., Leung, A., Henry, O.A., Victor, M.R., Paul, R.H., Medearis, A.L., Antepartum surveillance in diabetic pregnancies: predictors of fetal distress in labor. Am J Obstet Gynecol 173 (1995), 1532–1539.
55. Gmehlin, U., Stenz, R., Stoz, F., Metabolic acidosis in the 32nd week of pregnancy – uncontrolled diabetes in pregnancy, dehydration or sequela of tocolysis?. Zentralbl Gynakol 116 (1994), 706–710.
56. Rebarber, A., Istwan, N.B., Russo-Stieglitz, K., Cleary-Goldman, J., Rhea, D.J., Stanziano, G.J., et al. Increased incidence of gestational diabetes in women receiving prophylactic 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery. Diabetes Care 30 (2007), 2277–2280.
57. Waters, T.P., Schultz, B.A., Mercer, B.M., Catalano, P.M., et al. Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy. Obstet Gynecol 114 (2009), 45–49.
58. Gyamfi, C., Horton, A.L., Momirova, V., Rouse, D.J., Caritis, S.N., Peaceman, A.M., et al. The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies. Am J Obstet Gynecol, 201, 2009, 392 [e1-5].
59. Schumacher, A., Sidor, J., Buhling, K.J., Continuous glucose monitoring using the glucose sensor CGMS in metabolically normal pregnant women during betamethasone therapy for fetal respiratory distress syndrome. Z Geburtshilfe Neonatol 210 (2006), 184–190.
60. Mathiesen, E.R., Christensen, A.B., Hellmuth, E., Hornnes, P., Stage, E., Damm, P., et al. Insulin dose during glucocorticoid treatment for fetal lung maturation in diabetic pregnancy: test of an algorithm [correction of analgorithm]. Acta Obstet Gynecol Scand 81 (2002), 835–839.
61. Kaushal, K., Gibson, J.M., Railton, A., Hounsome, B., New, J.P., Young, R.J., et al. A protocol for improved glycaemic control following corticosteroid therapy in diabetic pregnancies. Diabet Med 20 (2003), 73–75.
62. Sotiriadis A, Makrydimas G, Papatheodorou S, Ioannidis JP. Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term. Cochrane Database Syst Rev 2009:CD006614.
63. Stutchfield, P., Whitaker, R., Russell, I., Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ, 331, 2005, 662.
64. Fisher, J.E., Smith, R.S., Lagrandeur, R., Lorenz, R.P., Gstational diabetes mellitus in women receiving beta-adrenergics and corticosteroids for threatened preterm delivery. Obstet Gynecol 90 (1997), 880–883.
65. Ballard, P.L., Granberg, P., Ballard, R.A., Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Invest 56 (1975), 1548–1554.